New in-office BPH laser treatment is efficient, cost-effective
Biolitec has launched the 150-watt Evolve side-firing diode laser unit, which the company says precisely ablates and coagulates prostate tissue, resulting in shorter procedures and recovery times.
Biolitec has launched the 150-watt Evolve side-firing diode laser unit, which the company says precisely ablates andcoagulates prostate tissue, resulting in shorter procedures and recovery times.
The 980-nm laser wavelength allows equal energy absorption in water and hemoglobin for effective, char-free coagulation andhemostasis with minimal complications and minimal post-treatment discomfort. The operator can select from continuous orpulsed-wave operation.
Procedures can be performed in the office in as little as 30 minutes per patient, and are reimbursed as in-officeprocedures.
Because the procedure requires only a prostatic block and a single injection of lidocaine, the patient remains conscious. Theneed for post-procedure catheterization is limited. In addition, patients can return home after a brief recovery periodwithout the expense of a hospital stay, although the manufacturer advises that patients with prostates larger than 80 grams beadmitted to a hospital.
The portable, air-cooled unit features plug-and-use simplicity and a space-saving footprint without the need for a dedicatedwater line.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
